期刊簡(jiǎn)介預(yù)計(jì)審稿時(shí)間：

JCO PO is a peer-reviewed, online-only, article-based journal publishing original research, reports, opinions, and reviews that advance the science and practice of precision oncology and define genomics- and other biomarker-driven clinical care of patients with cancer. Innovative and timely scientific and educational content provide a deeper understanding of actionable cancer genomics, personalized translational and clinical oncology research, and recent treatment advances based on tumor molecular profiling. The scope of publications includes all types of clinical research (basket trials, exceptional response results, informatics, computational approaches, mechanism and evidence-based case reports and small series of educational value), and extensive expert driven commentary, editorials and reviews considering the challenges and value of targeted therapies based on genomic analyses. JCO PO is published by the American Society of Clinical Oncology (ASCO).

JCO PO 是一本同行評(píng)審的在線文章型期刊，發(fā)表原創(chuàng)研究、報(bào)告、觀點(diǎn)和評(píng)論，推動(dòng)精準(zhǔn)腫瘤學(xué)的科學(xué)和實(shí)踐，并定義癌癥患者的基因組學(xué)和其他生物標(biāo)志物驅(qū)動(dòng)的臨床護(hù)理。創(chuàng)新且及時(shí)的科學(xué)和教育內(nèi)容提供了對(duì)可操作的癌癥基因組學(xué)、個(gè)性化轉(zhuǎn)化和臨床腫瘤學(xué)研究以及基于腫瘤分子分析的最新治療進(jìn)展的更深入了解。出版物范圍包括所有類型的臨床研究（籃子試驗(yàn)、特殊反應(yīng)結(jié)果、信息學(xué)、計(jì)算方法、機(jī)制和循證病例報(bào)告以及具有教育價(jià)值的小系列），以及大量專家驅(qū)動(dòng)的評(píng)論、社論和評(píng)論，考慮到基于基因組分析的靶向治療的挑戰(zhàn)和價(jià)值。 JCO PO 由美國(guó)臨床腫瘤學(xué)會(huì) (ASCO) 出版。

《Jco Precision Oncology》(Jco精準(zhǔn)腫瘤學(xué))編輯部通訊方式為T(mén)WO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, USA, PA, 19103。如果您需要協(xié)助投稿或潤(rùn)稿服務(wù)，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年，熟悉發(fā)表政策，可為您提供一對(duì)一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。